Jorge Parra-Ruiz1,2, V Ramos3, C Dueñas4, N M Coronado-Álvarez5,6, R Cabo-Magadán4, V Portillo-Tuñón4, D Vinuesa3, L Muñoz-Medina3, J Hernández-Quero3,5. 1. Servicio de Enfermedades Infecciosas, Hospital Universitario San Cecilio, Avda Dr. Olóriz 16, 18012, Granada, Spain. jordi@ugr.es. 2. Laboratorio de Investigación Anti Microbiana, Hospital Universitario San Cecilio, Granada, Spain. jordi@ugr.es. 3. Servicio de Enfermedades Infecciosas, Hospital Universitario San Cecilio, Avda Dr. Olóriz 16, 18012, Granada, Spain. 4. Servicio de Medicina Interna, Complejo Asistencial Universitario de Burgos, Burgos, Spain. 5. Laboratorio de Investigación Anti Microbiana, Hospital Universitario San Cecilio, Granada, Spain. 6. Unidad de Gestión Clínica de Laboratorio, Hospital Universitario San Cecilio, Granada, Spain.
Abstract
PURPOSE: Tuberculous meningitis (TBM) is one of the most serious and difficult to diagnose manifestations of TB. An ADA value >9.5 IU/L has great sensitivity and specificity. However, all available studies have been conducted in areas of high endemicity, so we sought to determine the accuracy of ADA in a low endemicity area. METHODS: This retrospective study included 190 patients (105 men) who had ADA tested in CSF for some reason. Patients were classified as probable/certain TBM or non-TBM based on clinical and Thwaite's criteria. Optimal ADA cutoff was established by ROC curves and a predictive algorithm based on ADA and other CSF biochemical parameters was generated. RESULTS: Eleven patients were classified as probable/certain TBM. In a low endemicity area, the best ADA cutoff was 11.5 IU/L with 91 % sensitivity and 77.7 % specificity. We also developed a predictive algorithm based on the combination of ADA (>11.5 IU/L), glucose (<65 mg/dL) and leukocytes (≥13.5 cell/mm(3)) with increased accuracy (Se: 91 % Sp: 88 %). CONCLUSIONS: Optimal ADA cutoff value in areas of low TB endemicity is higher than previously reported. Our algorithm is more accurate than ADA activity alone with better sensitivity and specificity than previously reported algorithms.
PURPOSE:Tuberculous meningitis (TBM) is one of the most serious and difficult to diagnose manifestations of TB. An ADA value >9.5 IU/L has great sensitivity and specificity. However, all available studies have been conducted in areas of high endemicity, so we sought to determine the accuracy of ADA in a low endemicity area. METHODS: This retrospective study included 190 patients (105 men) who had ADA tested in CSF for some reason. Patients were classified as probable/certain TBM or non-TBM based on clinical and Thwaite's criteria. Optimal ADA cutoff was established by ROC curves and a predictive algorithm based on ADA and other CSF biochemical parameters was generated. RESULTS: Eleven patients were classified as probable/certain TBM. In a low endemicity area, the best ADA cutoff was 11.5 IU/L with 91 % sensitivity and 77.7 % specificity. We also developed a predictive algorithm based on the combination of ADA (>11.5 IU/L), glucose (<65 mg/dL) and leukocytes (≥13.5 cell/mm(3)) with increased accuracy (Se: 91 % Sp: 88 %). CONCLUSIONS: Optimal ADA cutoff value in areas of low TB endemicity is higher than previously reported. Our algorithm is more accurate than ADA activity alone with better sensitivity and specificity than previously reported algorithms.
Entities:
Keywords:
Algorithm; Central system fluid; Meningitis; Tuberculosis
Authors: S V Rana; F Chacko; V Lal; S K Arora; S Parbhakar; Sanjeev K Sharma; K Singh Journal: Clin Neurol Neurosurg Date: 2010-03-29 Impact factor: 1.876
Authors: G E Thwaites; T T H Chau; K Stepniewska; N H Phu; L V Chuong; D X Sinh; N J White; C M Parry; J J Farrar Journal: Lancet Date: 2002-10-26 Impact factor: 79.321
Authors: H Erdem; D Ozturk-Engin; N Elaldi; S Gulsun; G Sengoz; A Crisan; I S Johansen; A Inan; M Nechifor; A Al-Mahdawi; R Civljak; M Ozguler; B Savic; N Ceran; B Cacopardo; A S Inal; M Namiduru; S Dayan; U Kayabas; E Parlak; A Khalifa; E Kursun; O R Sipahi; M Yemisen; A Akbulut; M Bitirgen; O Dulovic; B Kandemir; C Luca; M Parlak; J P Stahl; F Pehlivanoglu; S Simeon; A Ulu-Kilic; K Yasar; G Yilmaz; E Yilmaz; B Beovic; M Catroux; B Lakatos; M Sunbul; O Oncul; S Alabay; E Sahin-Horasan; S Kose; G Shehata; K Andre; A Alp; G Cosić; H Cem Gul; A Karakas; S Chadapaud; Y Hansmann; A Harxhi; V Kirova; I Masse-Chabredier; S Oncu; A Sener; R Tekin; O Deveci; O Karabay; C Agalar Journal: Clin Microbiol Infect Date: 2014-04-03 Impact factor: 8.067
Authors: Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais Journal: Lancet Infect Dis Date: 2010-09-06 Impact factor: 25.071
Authors: Cuong Chi Ngo; Shungo Katoh; Futoshi Hasebe; Bhim Gopal Dhoubhadel; Tomoko Hiraoka; Sugihiro Hamaguchi; Anh Thi Kim Le; Anh Thi Hien Nguyen; Anh Duc Dang; Chris Smith; Lay-Myint Yoshida; Cuong Duy Do; Thuy Thi Thanh Pham; Koya Ariyoshi Journal: Trop Med Health Date: 2021-05-21